Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-408,226
Closed -$14.1M 262
2016
Q1
$14.1M Buy
408,226
+24,470
+6% +$853K 1.83% 20
2015
Q4
$14.8M Sell
383,756
-35,340
-8% -$1.37M 1.63% 26
2015
Q3
$16.4M Buy
+419,096
New +$16.6M 1.65% 25

Other funds holding HOLX

Navellier & Associates's HOLX Position: Q2 2016 in Review

Navellier & Associates sold out of Hologic (HOLX) in Q2 2016, closing a stake of 408,226 shares — an estimated $14.1M sold.

Navellier & Associates first reported a position in HOLX in Q3 2015 and held it in 3 quarters. The position peaked at $16.4M in Q3 2015. 459 funds tracked by Wall St. Rank hold HOLX as of Q2 2016.

  • Navellier & Associates reported no remaining Hologic position as of Q2 2016 after selling out during the quarter.
  • Navellier & Associates sold 408,226 Hologic shares in Q2 2016, an estimated $14.1M.
  • Navellier & Associates first reported a position in Hologic in Q3 2015 and held it in 3 quarters.
  • Navellier & Associates's Hologic position peaked at $16.4M in Q3 2015.
  • 459 funds tracked by Wall St. Rank held Hologic as of Q2 2016.

Based on Navellier & Associates's 13F filing for Q2 2016, filed 3 Aug 2016.